Healthcare & Life Sciences
LogicBio
United Stateswww.logicbio.com
LogicBio is a Healthcare & Life Sciences startup based in the United States, since acquired, 2 tracked investors.
Acquiredacquired
acquired
Stage
2013
Founded
2
Investors
About LogicBio
Based in the United States, LogicBio is a startup founded in 2013. LogicBio has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
LogicBio was a clinical-stage genetic medicine company focused on developing gene therapies for rare diseases, utilizing its proprietary gene editing and gene delivery platforms. The company was acquired by Alexion, AstraZeneca's rare disease group, in 2022.
Explore LogicBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.